Clinical Trial Update: Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Magnevist-enhanced MRA to non-contrast MRA for detecting renal artery stenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Artery Stenosis

Drugs mentioned

• Magnevist (gadopentetate dimeglumine)

Snippet

Sponsor: Bayer | Conditions: Renal Artery Stenosis | Phase 3 | Status: COMPLETED